Discusses Preliminary Phase I Data for SIM0505 in Platinum-Resistant Ovarian Cancer and Uterine Serous Carcinoma June 2, 2026 8:00 ...

Welcome to the biology lesson you never had.

BioInvent International AB (publ) ( BOVNF) Discusses Ovarian Cancer Treatment Landscape and TNFR2-Targeted Therapies in Solid Tumors May 27, 2026 8:00 AM EDT Good morning, and welcome to the BioInvent ...

Dr. Nora Pope ND, FCP   A clinical exploration of how collaborative ND–NP care can bridge prescribing limitations, integrate ...

An estimated 1 in 8 women live with polycystic ovarian syndrome, commonly referred to as PCOS. However, the name is a bit of a misnomer; it suggests that the condition affects only the ovaries. In ...

While the number of eggs that women are born with is genetically predetermined, there are potential ways to optimize ovarian longevity and become an ova-achiever.

Nutrition advice is largely based on the idea that the body’s needs stay consistent from day to day. But anyone who menstruates knows their body goes on a roller-coaster ride throughout the month.

Polycystic ovary syndrome is being relabelled polyendocrine metabolic ovarian syndrome to correct the misconception that it is solely a gynaecological disease that creates ovarian cysts. Here’s what ...

Polycystic ovary syndrome (PCOS) has a new name: polyendocrine metabolic ovarian syndrome (PMOS). Women's health experts say the new name is more scientifically accurate and reflects that PMOS doesn't ...

Polycystic ovary syndrome (PCOS) is no more. The condition, of course, still exists. But on Tuesday a global science consortium announced the term will be thrown out. In a policy paper, the panel ...

Create a table consisting of data or use an existing table consisting of data. Now highlight the table and then go to the Insert tab and click the Object button. An Object dialog box will open. Scroll ...

A drug which is being investigated as treatment for a rare disease could extend the lives of patients with an aggressive form of ovarian cancer, according to a clinical trial. Platinum-resistant ...